Ludeman S M, Boyd V L, Regan J B, Gallo K A, Zon G, Ishii K
Drugs Exp Clin Res. 1986;12(6-7):527-32.
Ozonolysis of compounds with the general structure CH2 = CHR1CHR2CH2OP(O) (NHR3)NR42 gave, in each case, one major product which was an analogue of the cyclophosphamide (CP) metabolites aldophosphamide (AP) or 4-hydroxy-CP. 31P NMR spectra recorded for each of these compounds in aqueous buffered solutions at pH 7.4, 37 degrees C, revealed a cascade of reactions similar to those observed for AP and/or 4-hydroxy-CP, although the individual rate constants for these reactions were substituent-dependent. Aryl ketone analogues of AP did not give rise to detectable amounts of their cyclic hemiaminals, but those which produced phosphoramide mustards at rates similar to that found for AP were active against L1210 lymphoid leukaemia in mice. The results indicated that oncostatic selectivity may not require cell-specific oxidative detoxification.
对具有通式CH2 = CHR1CHR2CH2OP(O)(NHR3)NR42的化合物进行臭氧分解,在每种情况下都得到一种主要产物,该产物是环磷酰胺(CP)代谢物醛磷酰胺(AP)或4-羟基-CP的类似物。在pH 7.4、37℃的水性缓冲溶液中对这些化合物中的每一种记录的31P NMR光谱显示出一系列类似于AP和/或4-羟基-CP所观察到的反应,尽管这些反应的各个速率常数取决于取代基。AP的芳基酮类似物不会产生可检测量的其环状半缩醛胺,但那些以与AP相似的速率产生磷酰胺氮芥的类似物对小鼠L1210淋巴细胞白血病具有活性。结果表明,抑癌选择性可能不需要细胞特异性氧化解毒。